Blockade of β1- and β2-adrenoceptors delays wound contraction and re-epithelialization in rats

Clinical and Experimental Pharmacology and Physiology

Volumn 33, Issue 5-6, 2006, Pages 421-430

  Souza, Bruna R ^a   Santos, Jeanine S ^a   Costa, Andréa M A ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

adrenoceptors; Fibroblasts; Mast cells; Propranolol; Wound healing

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; COLLAGEN; CYCLINE; EOSIN; FORMALDEHYDE; HEMATOXYLIN; HYDROXYPROLINE; PARAFFIN; TOLONIUM CHLORIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CELL DENSITY; CELL PROLIFERATION; CONNECTIVE TISSUE CELL; CONTROLLED STUDY; EPIDERMIS; EPITHELIZATION; IMMUNOHISTOCHEMISTRY; LEUKOCYTE MIGRATION; MALE; MAST CELL; MYOFIBROBLAST; NONHUMAN; RAT; RECEPTOR BLOCKING; SKIN; STAINING; TISSUE FIXATION; WOUND CONTRACTION; WOUND HEALING; WOUND HEALING IMPAIRMENT; ADRENERGIC SYSTEM; ANGIOGENESIS; ANIMAL; CELL MOTION; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIUM CELL; GRANULATION TISSUE; INNERVATION; METABOLISM; NEUTROPHIL; PHYSIOLOGY; VASCULARIZATION; WISTAR RAT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; EPITHELIAL CELLS; GRANULATION TISSUE; MALE; MAST CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; NEUTROPHILS; PROPRANOLOL; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; SKIN; SYMPATHETIC NERVOUS SYSTEM; WOUND HEALING;

EID: 33745193953     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2006.04383.x     Document Type: Article

References (40)

1. Singer AJ, Clark RA. Cutaneous wound healing. N. Engl. J. Med. 1999 341 : 738 46.
2. Coderre TJ, Basbaum AI, Levine JD. Neural control of vascular permeability: Interactions between primary afferents, mast cells, and sympathetic efferents. J. Neurophysiol. 1989 62 : 48 58.
3. Kim LR, Whelpdale K, Zurowski M, Pomeranz B. Sympathetic denervation impairs epidermal healing in cutaneous wounds. Wound Repair Regen. 1998 6 : 194 201.
4. Kim LR, Pomeranz B. The sympathomimetic agent, 6-hydroxydopamine, accelerates cutaneous wound healing. Eur. J. Pharmacol. 1999 376 : 257 64.
5. Souza BR, Cardoso JF, Amadeu TP, Desmouliere A, Costa AM. Sympathetic denervation accelerates wound contraction but delays reepithelialization in rats. Wound Repair Regen. 2005 13 : 498 505.
6. Wallukat G. The beta-adrenergic receptors. Herz 2002 27 : 683 90.
7. Duell EA. Identification of a beta 2-adrenergic receptor in mammalian epidermis. Biochem. Pharmacol. 1980 29 : 97 101.
8. Leicht M, Greipel N, Zimmer H. Comitogenic effect of catecholamines on rat cardiac fibroblasts in culture. Cardiovasc. Res. 2000 48 : 274 84.
9. Colombo F, Noel J, Mayers P, Mercier I, Calderone A. beta-Adrenergic stimulation of rat cardiac fibroblasts promotes protein synthesis via the activation of phosphatidylinositol 3-kinase. J. Mol. Cell. Cardiol. 2001 33 : 1091 106.
10. Anesini C, Borda E. Modulatory effect of the adrenergic system upon fibroblast proliferation: Participation of beta 3-adrenoceptors. Auton. Autacoid Pharmacol. 2002 22 : 177 86.
11. Grando SA. Biological functions of keratinocyte cholinergic receptors. J. Invest. Dermatol. Symp. Proc. 1997 2 : 41 8.
12. Nosàl R, Drabikova K, Pecivova J, Ondrias K. Membrane perturbing activity of beta-adrenoceptor blocking drugs in isolated rat mast cells. Agents Actions 1989 27 : 36 8.
13. Junqueira LC, Montes GS, Martins JE, Joazeiro PP. Dermal collagen distribution. A histochemical and ultrastructural study. Histochemistry 1983 79 : 397 403.
14. Bancroft J, Cook H. Manual of Histological Techniques and Their Diagnostic Application. Churchill Livengstone, London. 1994.
15. Baddeley AJ, Gundersen HJ, Cruz-Orive LM. Estimation of surface area from vertical sections. J. Microsc. 1986 142 : 259 76.
16. Gundersen HJ, Bendtsen TF, Korbo L et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 1988 96 : 379 94.
17. Amadeu T, Braune A, Mandarim-de-Lacerda C, Porto LC, Desmouliere A, Costa A. Vascularization pattern in hypertrophic scars and keloids: A stereological analysis. Pathol. Res. Pract. 2003 199 : 469 73.
18. Sadoun E, Reed MJ. Impaired angiogenesis in aging is associated with alterations in vessel density, matrix composition, inflammatory response, and growth factor expression. J. Histochem. Cytochem. 2003 51 : 1119 30.
19. Cabral CA, Sampaio FJ, Cardoso LE. Analysis of the modifications in the composition of bladder glycosaminoglycan and collagen as a consequence of changes in sex hormones associated with puberty or oophorectomy in female rats. J. Urol. 2003 170 : 2512 16.
20. Woessner Jr JF. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch. Biochem. Biophys. 1961 93 : 440 7.
21. Lewis P. The essential action of propranolol in hypertension. Am. J. Med. 1976 60 : 837 52.
22. Metze D, Luger T. Nervous system in the skin. In : Woodley D (ed.). The Biology of the Skin. Parthenon Publishing, New York. 2001 265 94.
23. Nork TM, Holly FJ, Hayes J, Wentlandt T, Lamberts DW. Timolol inhibits corneal epithelial wound healing in rabbits and monkeys. Arch. Ophthalmol. 1984 102 : 1224 8.
24. Trope GE, Liu GS, Basu PK. Toxic effects of topically administered Betagan, Betoptic, and Timoptic on regenerating corneal epithelium. J. Ocul. Pharmacol. 1988 4 : 359 66.
25. Flaxman BA, Harper RA. In vitro analysis of the control of keratinocyte proliferation in human epidermis by physiologic and pharmacologic agents. J. Invest. Dermatol. 1975 65 : 52 9.
26. Yoshikawa K, Adachi K, Halprin KM, Levine V. The effects of catecholamine and related compounds on the adenyl cyclase system in the epidermis. Br. J. Dermatol. 1975 93 : 29 36.
27. Harris RR, Mackenzie IC. The effects of alpha and beta adrenergic agonists and cyclic adenosine 3′,5′-monophosphate on epidermal metabolism. J. Invest. Dermatol. 1981 77 : 337 40.
28. Davidson JM. Animal models for wound repair. Arch. Dermatol. Res. 1998 290 ( Suppl. S1 11.
29. Desmouliere A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen. 2005 13 : 7 12.
30. Diegelmann RF. Excessive neutrophils characterize chronic pressure ulcers. Wound Repair Regen. 2003 11 : 490 5.
31. Rivkin I, Rosenblatt J, Becker EL. The role of cyclic AMP in the chemotactic responsiveness and spontaneous motility of rabbit peritoneal neutrophils. The inhibition of neutrophil movement and the elevation of cyclic AMP levels by catecholamines, prostaglandins, theophylline and cholera toxin. J. Immunol. 1975 115 : 1126 34.
32. Yamazaki M, Matsuoka T, Yasui K, Komiyama A, Akabane T. Dopamine inhibition of superoxide anion production by polymorphonuclear leukocytes. J. Allergy Clin. Immunol. 1989 83 : 967 72.
33. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 2003 200 : 500 3.
34. Growcott JW, Wilson C, Holloway B, Mainwaring S. Evaluation of ICI D7114, a putative stimulant of brown adipocytes, on histamine-contracted guinea-pig ileum. Br. J. Pharmacol. 1993 109 : 1212 18.
35. Elliott GR, Amos HE, Miller K, Bridges JW. Practolol inhibits human skin fibroblast cell mat hydroxyproline accumulation. Agents Actions 1987 22 : 106 13.
36. Maurer M, Theoharides T, Granstein RD et al. What is the physiological function of mast cells? Exp. Dermatol. 2003 12 : 886 910.
37. Meininger CJ, Zetter BR. Mast cells and angiogenesis. Semin. Cancer Biol. 1992 3 : 73 9.
38. Eady RA, Cowen T, Marshall TF, Plummer V, Greaves MW. Mast cell population density, blood vessel density and histamine content in normal human skin. Br. J. Dermatol. 1979 100 : 623 33.
39. Azizkhan RG, Azizkhan JC, Zetter BR, Folkman J. Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J. Exp. Med. 1980 152 : 931 44.
40. Gruber BL, Marchese MJ, Kew R. Angiogenic factors stimulate mast-cell migration. Blood 1995 86 : 2488 93.